Australia markets closed

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.6000+0.1200 (+3.45%)
As of 01:15PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,013
1,013
4,749
13,832
4,992
Selling general and administrative
6,283
6,283
5,847
5,503
4,774
Total operating expenses
7,296
7,296
10,596
19,335
9,766
Operating income or loss
-7,296
-7,296
-10,596
-19,335
-9,766
Interest expense
-
-
-
0
9
Total other income/expenses net
-
-
-5
-
-
Income before tax
-5,339
-5,339
-9,926
-19,322
-9,747
Income tax expense
-
-
-
0
-9
Income from continuing operations
-5,339
-5,339
-9,926
-19,322
-9,738
Net income
-5,339
-5,339
-9,926
-19,322
-9,738
Net income available to common shareholders
-5,339
-5,339
-9,926
-19,322
-9,738
Basic EPS
-0.37
-0.37
-0.69
-1.39
-2.07
Diluted EPS
-0.37
-0.37
-0.69
-1.39
-2.07
Basic average shares
14,410
14,416
14,410
13,904
4,710
Diluted average shares
14,410
14,416
14,410
13,904
4,710